IHE Biosimilars Invitational Forum
About the IHE Biosimilars Invitational Forum
23 April 2017
On April 23rd, the IHE held an invitational forum on the topic of biosimilars in conjunction with the annual CADTH meeting.
Download Summary Report
Towards a framework for biosimilar evidence and knowledge exchange – Summary report of the IHE Biosimilars Forum
The meeting objectives were to:
- leverage a previous IHE Biosimilars Forum and share summary international biosimilar experience and a framework that identifies the enabling elements (e.g., policy, education, infrastructure, competition, evidence development) that will support health systems in Canada to achieve biosimilar objectives;
- identify key principles and a framework for how we categorize and interpret available evidence at time of biosimilar introduction, both to identify place in therapy as well as further evidence development that may be required, in order to support policy, purchasing, and clinical decision-making; and,
- identify an approach to knowledge exchange that will enable a common view and shared agreement amongst stakeholders regarding appropriate use of biosimilars given interpretation of the current state of evidence.